FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090918 [Registered on: 15/07/2025] Trial Registered Prospectively
Last Modified On: 14/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   Components of ERAS 
Scientific Title of Study   Components of non compliance to ERAS in curative surgery for gastrointestinal and gynaecological cancer- A prospective observational study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pooja 
Designation  Senior resident 
Affiliation   
Address  Ground floor, Department of surgical oncology,Aiims Bhubaneswar

Khordha
ORISSA
751019
India 
Phone  9996218768  
Fax    
Email  pooja.khandelwal77@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dillip Muduly 
Designation  Professor and Head of Department 
Affiliation  Aiims Bhubaneswar 
Address  Ground floor, Department of surgical oncology,Aiims Bhubaneswar

Khordha
ORISSA
751019
India 
Phone  9013072969  
Fax    
Email  dillipmuduly@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Dillip Muduly 
Designation  Professor and Head of Department 
Affiliation  Aiims Bhubaneswar 
Address  Ground floor, Department of surgical oncology,Aiims Bhubaneswar

Khordha
ORISSA
751019
India 
Phone  9013072969  
Fax    
Email  dillipmuduly@gmail.com  
 
Source of Monetary or Material Support  
Ground floor, Department of surgical oncology,Aiims Bhubaneswar 
 
Primary Sponsor  
Name  Aiims Bhubaneswar 
Address  Department of surgical oncology,Aiims Bhubaneswar, Khordha Odisha, 751019 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Pooja   Surgical oncology   Dr Pooja, AIIMS bbsr
Khordha
ORISSA 
09996218768

pooja.khandelwal77@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Aiims bhubneswar  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  observational  observational 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1 Gastrointestinal and gynaecological cancer,
2 willingness
3 willingness to follow up
4 curative surgery 
 
ExclusionCriteria 
Details  1 Extremes of age
2 non consent for participation or follow up
3 poor performance score 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
non compliance to ERAS protocol  2weeks, 4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Length of post operative stay, complicatoions, Reoperativion & readmission rate  3 weeks, 8 weeks 
 
Target Sample Size   Total Sample Size="132"
Sample Size from India="132" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="5"
Days="1" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Identification of common areas of non-compliance helps prioritize targeted staff and patient education, improving ERAS adherence.Improves patient outcomes by modifying perioperative practices where non-compliance is linked to increased complications or prolonged LOS. Facilitates protocol adaptation specific to cancer surgery patients (e.g., stoma patients, elderly with frailty), making ERAS more practical in real-world oncology settings.Data-driven quality improvement for institutional ERAS audits and QI cycles.Supports enhanced resource utilization by reducing unnecessary delays in recovery, discharge, and adjuvant therapy initiation.Improves patient satisfaction by identifying and addressing barriers (e.g., pain control, nausea) leading to non-compliance.Contributes to evidence generation for ERAS in low-middle income settings, addressing resource and patient population-specific barriers.


 
Close